» Articles » PMID: 31841808

Longitudinal Trends in Perfluoroalkyl and Polyfluoroalkyl Substances Among Multiethnic Midlife Women from 1999 to 2011: The Study of Women's Health Across the Nation

Overview
Journal Environ Int
Date 2019 Dec 17
PMID 31841808
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited information exists regarding longitudinal trends in midlife women's exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS). Further, little is known about how patterns of exposure differ by race/ethnicity and reproductive characteristics including parity and menopause.

Objective: We aimed to examine temporal variations in serum PFAS concentrations among midlife women from the Study of Women's Health Across the Nation.

Methods: Serum concentrations of 11 PFAS homologues were measured in 75 White, Black and Chinese women with blood samples collected in 1999-2000, 2002-2003, 2005-2006, and 2009-2011. Rates of changes in PFAS concentrations were calculated assuming a first-order elimination model. Associations between PFAS concentrations and race/ethnicity, menstruation and parity were evaluated with linear mixed models, adjusting for age, body mass index and study site.

Results: Serum concentrations of linear-chain perfluorooctanoic acid (n-PFOA), linear- and branched-chain perfluorooctane sulfonic acid (n-PFOS and sm-PFOS) decreased significantly (-6.0%, 95% CI: -8.3%, -3.6% per year for n-PFOA; -14.8%, 95% CI: -17.3%, -12.3% per year for n-PFOS; -16.9%, 95% CI: -19.1%, -14.6% per year for sm-PFOS); whereas perfluorononanoic acid (PFNA) increased (16.0%, 95% CI: 10.6%, 21.6% per year). Detection rates of perfluorodecanoic acid (PFDeA) and perfluoroundecanoic acid (PFUA) doubled. Temporal trends varied significantly by race/ethnicity. Chinese women tended to have consistently higher PFNA concentrations at each follow-up visit, compared with White and Black women. Serum PFHxS concentrations significantly decreased in White and Black women, but not in Chinese. Menstruating women consistently had lower concentrations. Parity was associated with lower concentrations at baseline but the differences between nulliparous and parous women became smaller over time.

Conclusions: Our results suggest longitudinal declines in serum concentrations of legacy PFAS and increases in serum concentrations of emerging compounds from 1999 to 2011 in midlife women. Temporal trends in PFAS concentrations are not uniform across race/ethnicity and parity groups.

Citing Articles

Per- and Polyfluoroalkyl Substances and Outcomes Related to Metabolic Syndrome: A Review of the Literature and Current Recommendations for Clinicians.

Hall A, Braun J Am J Lifestyle Med. 2025; 19(2):211-229.

PMID: 39981556 PMC: 11836584. DOI: 10.1177/15598276231162802.


Effects of Per- and Polyfluoroalkylated Substances on Female Reproduction.

Gonzalez-Alvarez M, Antwi-Boasiako C, Keating A Toxics. 2024; 12(7.

PMID: 39058107 PMC: 11280844. DOI: 10.3390/toxics12070455.


Temporal Trend of Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid among U.S. Adults with or without Comorbidities in NHANES 1999-2018.

Pan J, Ouyang C, Zhou S, Wang X, Liu H, Zhang J Toxics. 2024; 12(5).

PMID: 38787093 PMC: 11125848. DOI: 10.3390/toxics12050314.


PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women.

Arredondo Eve A, Tunc E, Mehta D, Yoo J, Yilmaz H, Emren S Toxicol Sci. 2024; 200(2):312-323.

PMID: 38758093 PMC: 11285195. DOI: 10.1093/toxsci/kfae065.


Exploring the Potential Link between PFAS Exposure and Endometrial Cancer: A Review of Environmental and Sociodemographic Factors.

Ayodele A, Obeng-Gyasi E Cancers (Basel). 2024; 16(5).

PMID: 38473344 PMC: 10931119. DOI: 10.3390/cancers16050983.


References
1.
Bach C, Vested A, Jorgensen K, Bonde J, Henriksen T, Toft G . Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review. Crit Rev Toxicol. 2016; 46(9):735-55. DOI: 10.1080/10408444.2016.1182117. View

2.
Wu X, Bennett D, Calafat A, Kato K, Strynar M, Andersen E . Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California. Environ Res. 2014; 136:264-73. PMC: 4724210. DOI: 10.1016/j.envres.2014.09.026. View

3.
Zhang S, Tan R, Pan R, Xiong J, Tian Y, Wu J . Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women. J Clin Endocrinol Metab. 2018; 103(7):2543-2551. DOI: 10.1210/jc.2017-02783. View

4.
Fei C, McLaughlin J, Lipworth L, Olsen J . Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod. 2009; 24(5):1200-5. DOI: 10.1093/humrep/den490. View

5.
Olsen G, Lange C, Ellefson M, Mair D, Church T, Goldberg C . Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ Sci Technol. 2012; 46(11):6330-8. DOI: 10.1021/es300604p. View